Once-Weekly Semaglutide 2.4 mg Improved Glucose Metabolism and Prediabetes in Adults with Overweight/Obesity in the STEP 1 Trial

被引：0
|
作者：
Perreault, Leigh
Davies, Melanie J.
Frias, Juan P.
Laursen, Peter N.
Lingvay, Ildiko
Machineni, Sriram
Varbo, Anette
Wilding, John
Wallenstein, Signe O. R.
Le Roux, Carel
机构：
来源：
DIABETES | 2021年 / 70卷
关键词：
D O I：
10.2337/db21-81-OR
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
81-OR
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Once-weekly semaglutide 2.4 mg improved glucose metabolism and prediabetes in adults with overweight or obesity in the STEP 1 trial
    Perreault, L.
    Davies, M.
    Frias, J. P.
    Laursen, P. N.
    Lingvay, I.
    Machineni, S.
    Varbo, A.
    Wilding, J. P. H.
    Wallenstein, S. O. R.
    Le Roux, C. W.
    DIABETOLOGIA, 2021, 64 (SUPPL 1) : 234 - 234
  • [2] Once-weekly semaglutide 2.4mg improved metabolic syndrome in adults with overweight or obesity: post hoc analysis of the STEP 1 trial
    Khan, Omar
    le Roux, Carel
    Davies, Melanie
    Frias, Juan
    Laursen, Peter Norkjaer
    Lingvay, Ildiko
    Machineni, Sriram
    Varbo, Anette
    Wilding, John
    Wallenstein, Signe
    Perreault, Leigh
    OBESITY SURGERY, 2022, 32 (SUPPL 1) : 32 - 32
  • [3] Once-Weekly Semaglutide in Adults with Overweight or Obesity
    Javor, Eugen
    Lucijanic, Marko
    Skelin, Marko
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (01):
  • [4] Once-Weekly Semaglutide in Adults with Overweight or Obesity
    Wilding, John P. H.
    Batterham, Rachel L.
    Calanna, Salvatore
    Davies, Melanie
    Van Gaal, Luc F.
    Lingvay, Ildiko
    McGowan, Barbara M.
    Rosenstock, Julio
    Tran, Marie T. D.
    Wadden, Thomas A.
    Wharton, Sean
    Yokote, Koutaro
    Zeuthen, Niels
    Kushner, Robert F.
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (11): : 989 - 1002
  • [5] Changes in Glucose Metabolism and Glycemic Status With Once-Weekly Subcutaneous Semaglutide 2.4 mg Among Participants With Prediabetes in the STEP Program
    Perreault, Leigh
    Davies, Melanie
    Frias, Juan P.
    Laursen, Peter Norkjaer
    Lingvay, Ildiko
    Machineni, Sriram
    Varbo, Anette
    Wilding, John P. H.
    Wallenstein, Signe Olrik Rytter
    le Roux, Carel W.
    DIABETES CARE, 2022, 45 (10) : 2396 - 2405
  • [6] Once-weekly subcutaneous semaglutide 2.4 mg reduces body weight in adults with overweight or obesity regardless of baseline characteristics (STEP 1)
    Garvey, W. Timothy
    Hesse, Dan
    Joseph, Frank
    Koroleva, Anna
    Kushner, Robert F.
    le Roux, Carel W.
    Lim, Soo
    Lingvay, Ildiko
    Mosenzon, Ofri
    Wallenstein, Signe O. R.
    Wadden, Thomas A.
    OBESITY SURGERY, 2021, 31 (SUPPL 1) : S11 - S11
  • [7] Semaglutide 2.4 mg improved glucose metabolism and reverted prediabetes to normoglycaemia in adults with overweight or obesity vs liraglutide 3.0 mg (STEP 8)
    Rubino, D. M.
    Garvey, T. W.
    Goldman, B.
    Khalid, U.
    Rosenstock, J.
    Sorrig, R.
    DIABETOLOGIA, 2022, 65 (SUPPL 1) : S287 - S288
  • [8] Semaglutide 2.4 mg improved glucose metabolism and reverted prediabetes to normoglycaemia in adults with overweight or obesity vs liraglutide 3.0 mg (STEP 8)
    Idris, Iskandar
    Rubino, Domenica
    Garvey, W. Timothy
    Goldman, Bryan
    Khalid, Usman
    Rosenstock, Julio
    Sorrig, Rasmus
    OBESITY SURGERY, 2023, 33 : S39 - S39
  • [9] Once-Weekly Semaglutide in Adults with Overweight or Obesity REPLY
    Wilding, John P. H.
    Calanna, Salvatore
    Kushner, Robert F.
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (01):
  • [10] Improvement in insulin sensitivity and glucose metabolism in adolescents with obesity treated with once-weekly semaglutide 2.4 mg: a secondary analysis of the STEP TEENS trial
    Arslanian, Silva
    Goldman, Bryan
    Gies, Inge
    Harder-Lauridsen, Nina M.
    Karlsson, Tobias
    Kelly, Aaron
    Wabitsch, Martin
    Weghuber, Daniel
    HORMONE RESEARCH IN PAEDIATRICS, 2023, 96 : 76 - 76
12345